BIOX ApS: Financial statements 2022
CVR: 40237216
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOX ApS (CVR 40237216) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,102 and a net result of DKK -68,987 compared with DKK -69,748 the year before. Equity in the 2022 report amounted to DKK 514,961. The solvency ratio was 47.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,102
- Profit/Loss
- DKK -68,987
- Equity
- DKK 514,961
- Total Assets
- DKK 1,091,248
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2 t. | -69 t. | 515 t. | 1 |
| 2021 | - | -71 t. | -70 t. | 584 t. | 1 |
| 2020 | - | -79 t. | -442 t. | 654 t. | 2 |
| 2019 | - | -65 t. | -130 t. | -80 t. | 1 |
Keep an eye on BIOX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOX ApS has published its annual report for 2021. Gross profit came to DKK -71,158, and the net result was DKK -69,748.
About BIOX ApS
BIOX ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Lindblad. The company's owners include LOVISION ApS, BiA ApS and Genesis Invest ApS. In 2025, the company reported a gross profit of DKK 20,636 and a net result of DKK 15,931 compared with DKK -5,706 the year before. Equity in the 2025 report amounted to DKK 1,007,937.